PURE - PURE Bioscience Stock Price, News & Analysis

$1.00 0.00 (0.00 %)
(As of 11/22/2017 04:00 PM ET)
Previous Close$1.01
Today's Range$1.00 - $1.02
52-Week Range$0.75 - $1.36
Volume58,820 shs
Average Volume37,589 shs
Market Capitalization$67.93 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.41

About PURE Bioscience (OTCMKTS:PURE)

PURE Bioscience logoPURE Bioscience, Inc. is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company's technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC). It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains and food processors. It is testing and continuing development of PURE Control to utilize PURE Control as a direct food contact processing aid for raw meats, including beef and pork. In addition to PURE Hard Surface and PURE Control, it manufactures and sells SDC-based products for end use; products preserved with SDC, and SDC as a raw material ingredient for manufacturing use. These products include PURE Multi-Purpose and Floor Cleaner Concentrate, PURE Multi-Purpose Hi-Foam Cleaner Concentrate, Axen 30, Axenohl and SILVERION.


Industry, Sector and Symbol:
  • Industry: Chemicals - Major Diversified
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: OTCMKTS:PURE
  • CUSIP: N/A
  • Web: www.purebio.com
Debt:
  • Current Ratio: 0.97%
  • Quick Ratio: 0.87%
Sales & Book Value:
  • Annual Sales: $1.83 million
  • Price / Sales: 37.12
  • Book Value: $0.02 per share
  • Price / Book: 50.00
Profitability:
  • Trailing EPS: ($0.10)
  • Net Income: $-6,260,000.00
  • Net Margins: -342.05%
  • Return on Equity: -208.61%
  • Return on Assets: -110.10%
Misc:
  • Employees: 13
  • Outstanding Shares: 67,930,000
 

Frequently Asked Questions for PURE Bioscience (OTCMKTS:PURE)

What is PURE Bioscience's stock symbol?

PURE Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How were PURE Bioscience's earnings last quarter?

PURE Bioscience (OTCMKTS:PURE) announced its quarterly earnings data on Wednesday, March, 4th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.04). The company earned $0.27 million during the quarter, compared to analysts' expectations of $0.20 million. PURE Bioscience had a negative net margin of 342.05% and a negative return on equity of 208.61%. View PURE Bioscience's Earnings History.

When will PURE Bioscience make its next earnings announcement?

PURE Bioscience is scheduled to release their next quarterly earnings announcement on Wednesday, December, 13th 2017. View Earnings Estimates for PURE Bioscience.

Who are some of PURE Bioscience's key competitors?

Who are PURE Bioscience's key executives?

PURE Bioscience's management team includes the folowing people:

  • David Pfanzelter, Chairman of the Board (Age 63)
  • Henry R. Lambert, Chief Executive Officer, Director (Age 65)
  • Mark Elliott, Chief Financial Officer, Chief Accounting Officer, Vice President - Finance (Age 41)
  • Gary D. Cohee, Director (Age 70)
  • Elisabeth Hagen M.D., Independent Director
  • Tom Y. Lee CPA, Independent Director (Age 67)
  • William Otis, Independent Director (Age 60)
  • Janet Risi, Independent Director

How do I buy PURE Bioscience stock?

Shares of PURE Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PURE Bioscience's stock price today?

One share of PURE Bioscience stock can currently be purchased for approximately $1.00.

How big of a company is PURE Bioscience?

PURE Bioscience has a market capitalization of $67.93 million and generates $1.83 million in revenue each year. The company earns $-6,260,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. PURE Bioscience employs 13 workers across the globe.

How can I contact PURE Bioscience?

PURE Bioscience's mailing address is 1725 GILLESPIE WAY, EL CAJON, CA 92020-1015, United States. The company can be reached via phone at +1-619-5968600.


MarketBeat Community Rating for PURE Bioscience (PURE)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  56
MarketBeat's community ratings are surveys of what our community members think about PURE Bioscience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for PURE Bioscience (OTCMKTS:PURE)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for PURE Bioscience (OTCMKTS:PURE)

Price Target History for PURE Bioscience (OTCMKTS:PURE)

Analysts' Ratings History for PURE Bioscience (OTCMKTS:PURE)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History and Estimates Chart for PURE Bioscience (OTCMKTS:PURE)

Earnings by Quarter for PURE Bioscience (OTCMKTS:PURE)

Earnings History by Quarter for PURE Bioscience (OTCMKTS PURE)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/13/2017        
6/8/2017Q3 2017($0.02)($0.02)$1.00 million$0.34 millionViewListenView Earnings Details
3/4/2015($0.04)($0.04)$0.20 million$0.27 millionViewN/AView Earnings Details
12/11/2014($0.06)($0.05)$0.30 million$0.12 millionViewN/AView Earnings Details
10/28/2014($0.07)($0.09)$0.36 million$0.13 millionViewN/AView Earnings Details
6/10/2014Q314($0.05)($0.07)$0.26 million$0.26 millionViewN/AView Earnings Details
12/12/2013Q1 14($0.06)($0.19)ViewN/AView Earnings Details
12/12/2012-0.25($0.25)$0.26 million$0.26 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PURE Bioscience (OTCMKTS:PURE)
Current Year EPS Consensus Estimate: $-0.06 EPS
Next Year EPS Consensus Estimate: $0.01 EPS

Dividends

Dividend History for PURE Bioscience (OTCMKTS:PURE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for PURE Bioscience (OTCMKTS PURE)

Insider Ownership Percentage: 16.38%
Institutional Ownership Percentage: 0.24%
Insider Trades by Quarter for PURE Bioscience (OTCMKTS:PURE)

Insider Trades by Quarter for PURE Bioscience (OTCMKTS PURE)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/12/2017Henry R. LambertCEOSell3,301$0.95$3,135.95View SEC Filing  
12/21/2016Tom Y. LeeDirectorSell14,885$0.95$14,140.75View SEC Filing  
8/1/2014William OtisDirectorBuy20,000$0.85$17,000.00View SEC Filing  
7/18/2014David M ThenoDirectorBuy30,000$0.85$25,500.00View SEC Filing  
7/2/2014David J PfanzelterDirectorBuy35,294$0.85$29,999.90View SEC Filing  
11/1/2013Henry R LambertCEOBuy40,000$0.75$30,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PURE Bioscience (OTCMKTS PURE)

Source:
DateHeadline
FY2019 EPS Estimates for PURE Bioscience (PURE) Boosted by Zacks Investment ResearchFY2019 EPS Estimates for PURE Bioscience (PURE) Boosted by Zacks Investment Research
www.americanbankingnews.com - November 18 at 10:56 AM
PURE Bioscience (PURE) Cut to "Sell" at ValuEnginePURE Bioscience (PURE) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - November 16 at 11:34 PM
PURE Bioscience to Present at the 10th Annual LD Micro ConferencePURE Bioscience to Present at the 10th Annual LD Micro Conference
finance.yahoo.com - November 15 at 7:44 AM
PURE Bioscience (PURE) Lowered to "Sell" at ValuEnginePURE Bioscience (PURE) Lowered to "Sell" at ValuEngine
www.americanbankingnews.com - November 10 at 10:34 PM
PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety ConsultantPURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant
finance.yahoo.com - November 4 at 9:40 AM
PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q4, 2017 By the Numbers : October 30, 2017PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q4, 2017 By the Numbers : October 30, 2017
finance.yahoo.com - November 1 at 7:47 AM
Analyzing Tronox (TROX) and PURE Bioscience (PURE)Analyzing Tronox (TROX) and PURE Bioscience (PURE)
www.americanbankingnews.com - October 27 at 7:24 PM
PURE Bioscience Announces Partnership with iGPS LogisticsPURE Bioscience Announces Partnership with iGPS Logistics
finance.yahoo.com - October 27 at 12:15 PM
Pure Bioscience, Inc. to Host Earnings CallPure Bioscience, Inc. to Host Earnings Call
finance.yahoo.com - October 27 at 12:15 PM
PURE Bioscience Reports Fiscal 2017 Year-End Financial ResultsPURE Bioscience Reports Fiscal 2017 Year-End Financial Results
finance.yahoo.com - October 27 at 12:15 PM
Edited Transcript of PURE earnings conference call or presentation 26-Oct-17 8:30pm GMTEdited Transcript of PURE earnings conference call or presentation 26-Oct-17 8:30pm GMT
finance.yahoo.com - October 27 at 12:15 PM
Tronox (TROX) versus PURE Bioscience (PURE) Critical ReviewTronox (TROX) versus PURE Bioscience (PURE) Critical Review
www.americanbankingnews.com - October 27 at 3:30 AM
PURE Bioscience (PURE) Issues  Earnings Results, Beats Estimates By $0.01 EPSPURE Bioscience (PURE) Issues Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - October 27 at 12:50 AM
Tronox (TROX) vs. PURE Bioscience (PURE) Financial ReviewTronox (TROX) vs. PURE Bioscience (PURE) Financial Review
www.americanbankingnews.com - October 23 at 6:34 AM
PURE Bioscience (PURE) Set to Announce Quarterly Earnings on ThursdayPURE Bioscience (PURE) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - October 19 at 4:28 AM
As Bayer preps to vacate RTP, BASF readies for growthAs Bayer preps to vacate RTP, BASF readies for growth
www.bizjournals.com - October 17 at 4:20 PM
PURE Bioscience Announces Superior In-Plant Poultry Parts Test Results With PURE Control® AntimicrobialPURE Bioscience Announces Superior In-Plant Poultry Parts Test Results With PURE Control® Antimicrobial
finance.yahoo.com - October 14 at 7:05 AM
PURE Bioscience Completes Successful Warrant Tender Offer and Raises $2.8 Million from Exercise of WarrantsPURE Bioscience Completes Successful Warrant Tender Offer and Raises $2.8 Million from Exercise of Warrants
finance.yahoo.com - October 13 at 8:25 AM
Comparing PURE Bioscience (PURE) & Tronox (TROX)Comparing PURE Bioscience (PURE) & Tronox (TROX)
www.americanbankingnews.com - October 10 at 10:20 PM
Financial Analysis: PURE Bioscience (PURE) and Ashland Global Holdings (ASH)Financial Analysis: PURE Bioscience (PURE) and Ashland Global Holdings (ASH)
www.americanbankingnews.com - October 10 at 6:26 AM
PURE Bioscience (PURE) and Tronox (TROX) Financial ComparisonPURE Bioscience (PURE) and Tronox (TROX) Financial Comparison
www.americanbankingnews.com - October 9 at 2:26 AM
Financial Review: PURE Bioscience (PURE) & Ashland Global Holdings (ASH)Financial Review: PURE Bioscience (PURE) & Ashland Global Holdings (ASH)
www.americanbankingnews.com - October 6 at 2:12 PM
PURE Bioscience to Host Fiscal 2017 Year-End Financial Results Conference CallPURE Bioscience to Host Fiscal 2017 Year-End Financial Results Conference Call
finance.yahoo.com - October 3 at 11:14 AM
PURE Bioscience (PURE) versus Ashland Global Holdings (ASH) Head-To-Head ReviewPURE Bioscience (PURE) versus Ashland Global Holdings (ASH) Head-To-Head Review
www.americanbankingnews.com - September 28 at 10:50 PM
PURE Bioscience (PURE) Presents At SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC - SlideshowPURE Bioscience (PURE) Presents At SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC - Slideshow
seekingalpha.com - September 28 at 7:49 PM
Analyzing Ashland Global Holdings (ASH) & PURE Bioscience (PURE)Analyzing Ashland Global Holdings (ASH) & PURE Bioscience (PURE)
www.americanbankingnews.com - September 27 at 6:22 AM
Financial Review: Ashland Global Holdings (ASH) and PURE Bioscience (PURE)Financial Review: Ashland Global Holdings (ASH) and PURE Bioscience (PURE)
www.americanbankingnews.com - September 27 at 4:28 AM
Head-To-Head Comparison: Ashland Global Holdings (ASH) & PURE Bioscience (PURE)Head-To-Head Comparison: Ashland Global Holdings (ASH) & PURE Bioscience (PURE)
www.americanbankingnews.com - September 22 at 8:40 PM
Ashland Global Holdings (ASH) vs. PURE Bioscience (PURE) Head to Head AnalysisAshland Global Holdings (ASH) vs. PURE Bioscience (PURE) Head to Head Analysis
www.americanbankingnews.com - September 21 at 4:28 AM
PURE Bioscience (PURE) and Ashland Global Holdings (ASH) Financial ComparisonPURE Bioscience (PURE) and Ashland Global Holdings (ASH) Financial Comparison
www.americanbankingnews.com - September 19 at 12:56 PM
Critical Contrast: PURE Bioscience (PURE) and Ashland Global Holdings (ASH)Critical Contrast: PURE Bioscience (PURE) and Ashland Global Holdings (ASH)
www.americanbankingnews.com - September 15 at 10:12 PM
PURE Bioscience to Present at 2017 SeeThru Equity Investor ConferencePURE Bioscience to Present at 2017 SeeThru Equity Investor Conference
finance.yahoo.com - September 14 at 9:32 AM
Pure Bios Control antimicrobial included in approved list of safe ingredients for meat, poultry and egg product productionPure Bio's Control antimicrobial included in approved list of safe ingredients for meat, poultry and egg product production
seekingalpha.com - August 23 at 10:18 AM
PURE Control® Antimicrobial Listed as Safe and Suitable Ingredient in the USDA-FSIS Directive 7120.1 for Poultry ProductsPURE Control® Antimicrobial Listed as Safe and Suitable Ingredient in the USDA-FSIS Directive 7120.1 for Poultry Products
finance.yahoo.com - August 23 at 10:18 AM
PURE Bioscience to Present at 2017 Southern California Investor ConferencePURE Bioscience to Present at 2017 Southern California Investor Conference
finance.yahoo.com - August 11 at 7:50 AM
PURE Bioscience Appoints Food Supply Chain Executive Janet Risi to its Board of DirectorsPURE Bioscience Appoints Food Supply Chain Executive Janet Risi to its Board of Directors
finance.yahoo.com - July 29 at 6:31 AM
SeeThruEquity Initiates Coverage on PURE Bioscience (PURE) with a Price Target of $2.45SeeThruEquity Initiates Coverage on PURE Bioscience (PURE) with a Price Target of $2.45
finance.yahoo.com - July 19 at 5:41 AM
Roka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE BioscienceRoka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience
finance.yahoo.com - July 11 at 6:56 AM
PURE Bioscience Announces Co-Marketing and Supply Agreement with Roka Bioscience, Inc.PURE Bioscience Announces Co-Marketing and Supply Agreement with Roka Bioscience, Inc.
finance.yahoo.com - July 11 at 6:56 AM
PURE Biosciences (PURE) CEO Hank Lambert on Q3 2017 Results - Earnings Call TranscriptPURE Bioscience's (PURE) CEO Hank Lambert on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - June 9 at 1:16 AM
BRIEF-Pure Bioscience reports Q3 loss per share of $0.03BRIEF-Pure Bioscience reports Q3 loss per share of $0.03
www.reuters.com - June 9 at 1:16 AM
Yield10 Biosciences (YTEN) CEO Oli Peoples on Q1 2017 Results - Earnings Call TranscriptYield10 Bioscience's (YTEN) CEO Oli Peoples on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 8:08 AM
Cellectar Biosciences (CLRB) CEO Jim Caruso on Q1 2017 Results - Earnings Call TranscriptCellectar Biosciences' (CLRB) CEO Jim Caruso on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 12:51 AM
PURE Biosciences (PURE) CEO Hank Lambert on Q2 2017 Results - Earnings Call TranscriptPURE Bioscience's (PURE) CEO Hank Lambert on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - March 2 at 7:32 PM
PURE BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly ReportPURE BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - March 2 at 7:32 PM
Q2 2017 PURE Biosciences Inc Earnings Release - After Market CloseQ2 2017 PURE Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - March 2 at 8:25 AM
Coherus BioSciences to Report Fourth Quarter and Full Year 2016 Financial Results on March 13thCoherus BioSciences to Report Fourth Quarter and Full Year 2016 Financial Results on March 13th
globenewswire.com - February 21 at 5:29 PM
PURE BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a VotePURE BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote
biz.yahoo.com - January 20 at 9:10 PM
Meridian Bioscience Partners MedCaptain, Expands in ChinaMeridian Bioscience Partners MedCaptain, Expands in China
www.zacks.com - December 21 at 8:36 AM
PURE BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhPURE BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
us.rd.yahoo.com - December 15 at 9:27 PM

Social Media

Financials

Chart

PURE Bioscience (OTCMKTS PURE) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.